pRevTRE MKL1 Citations (3)

Originally described in: Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.
Muehlich S, Wang R, Lee SM, Lewis TC, Dai C, Prywes R Mol Cell Biol. 2008 Oct;28(20):6302-13. doi: 10.1128/MCB.00427-08. Epub 2008 Aug 11. PubMed Journal

---

Articles Citing pRevTRE MKL1

Articles
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Tello-Lafoz M, Srpan K, Sanchez EE, Hu J, Remsik J, Romin Y, Calo A, Hoen D, Bhanot U, Morris L, Boire A, Hsu KC, Massague J, Huse M, Er EE. Immunity. 2021 May 11;54(5):1037-1054.e7. doi: 10.1016/j.immuni.2021.02.020. Epub 2021 Mar 22. PubMed
Multiplex imaging reveals novel patterns of MRTFA/B activation in the breast cancer microenvironment. Wilk SM, Lee K, Castillo CC, Haloul M, Gajda AM, Macias V, Wiley EL, Chen Z, Liu X, Wang X, Sverdlov M, Hoskins KF, Er EE. J Transl Med. 2025 May 30;23(1):599. doi: 10.1186/s12967-025-06559-3. PubMed
Ionic regulation of cancer cell stiffness and metastatic colonization via the MRTFA-KCNMB1 axis. Gajda AM, Haloul M, Pai V, Mollaeian K, Patel KJ, Rodriguez-Lopez R, Beverley KM, Sanborn MA, Lee K, Castillo CC, Wilk SM, Wolska BM, Hossen F, Mendenhall EN, Lee JC, Levitan I, Rehman J, Er EE. Dev Cell. 2026 Jun 10;61(6):1223-1237.e7. doi: 10.1016/j.devcel.2026.05.001. Epub 2026 Jun 2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.